Medical malpractice carriers giving, getting leeway in face of COVID-19 pandemic
Medical malpractice insurers have responded with flexibility as their clients deal with liability concerns produced by the COVID-19 pandemic, writes Tom Jacobs for S&P Global Market Intelligence.
Tiger Joyce, president of the American Tort Reform Association, said concepts of liability and delivery of healthcare have been “fundamentally altered” by the pandemic.
“It has affected considerations about duty of care, appropriate decision making … with respect to looking at a particular scenario, or a particular patient or circumstances,” Joyce said in an interview. “It is a circumstance that’s … truly unprecedented.”
ATRA praises the passage of HB 6030 in Michigan, enacting COVID-19 liability protections.
ATRA’s statement on the Supreme Court of Pennsylvania’s ruling in Hammons v. Ethicon to allow an out-of-state lawsuit to continue, openly defying SCOTUS precedent.
Amanda Bronstad with Law.com writes about the potential repercussions if the 2019 $465 million judgment against Johnson & Johnson stands.
ATRA files amicus brief in support of Johnson & Johnson’s decision to appeal a 2019 $465 million judgment against the company, warning against the state attorney general’s expansive use of public nuisance law.
ATRA President Tiger Joyce spoke with Juliette Farley of the Southern California Record about Lawsuit Abuse Awareness Week and business interruption lawsuits.